When a government issues a compulsory license, it allows a third party, usually a generic drug manufacturer, to produce and distribute a patented drug without the consent of the patent holder. The patent holder is still entitled to receive fair compensation for the use of their invention, but the terms are typically negotiated or set by the government.
